Volume 63, Pages S88-S90 (June 2003)

Slides:

Advertisements

Similar presentations

Parathyroidectomy: Whom and when?

Advertisements

Steven Fishbane, Jeffrey S. Berns, M.D. Kidney International

E. Cavalier, P. Delanaye, A. Carlisi, J. -M. Krzesinski, J. -P

Volume 67, Pages S1-S7 (June 2005)

Cellular mechanisms of renal osteodystrophy

S.J. Nessim, S.V. Jassal, S.V. Fung, C.T. Chan Kidney International

Anemia management in chronic kidney disease

Volume 63, Pages S32-S38 (June 2003)

Parathyroidectomy: Whom and when?

Reassessment of the care of the patient with chronic kidney disease

Progression of renal failure and hypertensive nephrosclerosis

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Volume 76, Pages S50-S99 (August 2009)

George A. Kaysen, Burl R. Don

A new era in phosphate binder therapy: What are the options?

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Volume 78, Pages S33-S36 (August 2010)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

S.J. Nessim, S.V. Jassal, S.V. Fung, C.T. Chan Kidney International

Nephrology Crosswords: Hemodialysis

The epidemiology of chronic kidney disease

Use of vitamin D in chronic kidney disease patients

Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover.

Volume 79, Issue 1, Pages (January 2011)

Edmund G. Lowrie Kidney International

Study of Heart and Renal Protection (SHARP)

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

Volume 73, Pages S5-S17 (April 2008)

The calcium–phosphorus in guidelines for CKD-MBD

Blood pressure targets in hemodialysis patients

Volume 63, Pages S115-S118 (June 2003)

Volume 74, Pages S88-S93 (December 2008)

Volume 75, Issue 11, Pages (June 2009)

Role of vitamin D receptor activators on cardiovascular risk

Volume 56, Pages S31-S37 (December 1999)

New insights in uremic toxins

Effects of hemodialysis on cardiac function

Volume 61, Issue 6, Pages (June 2002)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Nephrology in Latin America, with special emphasis on Brazil

Volume 87, Issue 3, Pages (March 2015)

Alternate-day dialysis may be needed for hemodialysis patients

Nephrology Crossword: Peritoneal Dialysis

Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia

AGEs in foods: Do they play a role in uremia?

Simvastatin in nephrotic syndrome

Counteracting progression of renal disease: A look into the future

Pathogenesis of refractory secondary hyperparathyroidism

Nephrology Crossword: Glomerulonephritis

Fibroblast growth factor 23: the making of a hormone

Volume 53, Issue 5, Pages (May 1998)

Volume 56, Issue 3, Pages (September 1999)

Volume 63, Pages S79-S82 (June 2003)

Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.

Current status of maintenance hemodialysis in Beijing, China

Organ transplantation goes to the movies

Volume 56, Pages S71-S74 (November 1999)

Volume 55, Pages S3-S16 (June 1999)

Charles A. Herzog Kidney International

Recent developments in the management of secondary hyperparathyroidism

Volume 70, Issue 5, Pages (September 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Evaluation of the Losartan in Hemodialysis (ELHE) Study

Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis.

Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis Karl-Georg Fischer, M.D., Andreas van.

Volume 57, Issue 2, Pages (October 2000)

Volume 55, Pages S41-S46 (June 1999)

Characteristics of sudden death in hemodialysis patients

Volume 64, Pages S131-S136 (November 2003)

Presentation transcript:

Volume 63, Pages S88-S90 (June 2003) Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing hemodialysis Jose-Vicente Torregrosa, Agustin Moreno, Merçe Mas, Joan Ybarra, David Fuster Kidney International Volume 63, Pages S88-S90 (June 2003) DOI: 10.1046/j.1523-1755.63.s85.21.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Bone mineral density evolution expressed as T-score. Kidney International 2003 63, S88-S90DOI: (10.1046/j.1523-1755.63.s85.21.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 iPTH evolution (responders and non-responders) and calcitriol dose throughout the study period. Kidney International 2003 63, S88-S90DOI: (10.1046/j.1523-1755.63.s85.21.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Ca and P blood levels throughout the study period. R is the PTH responder group and Non-R is the PTH non-responder group. Kidney International 2003 63, S88-S90DOI: (10.1046/j.1523-1755.63.s85.21.x) Copyright © 2003 International Society of Nephrology Terms and Conditions